G6PD and Schnyder corneal dystrophy: Regarding their utility as disease severity biomarkers, it has been shown that the RMV levels have positive correlations with clinical markers of SCD (namely occlusive events and aortic stiffness) [30,75] as well as with the enzymatic activity of G6PD in G6PD deficient patients [77].